参考文献/References:
[1]WRITING COMMITTEE MEMBERS,Yancy CW,Jessup M,et al.2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure:An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J].Circulation,2016,134(13):e282-293. [2]Ponikowski P,Voors AA,Anker SD,et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur Heart J,2016,37(27):2129-2200. [3]Yin Z,Ren J,Guo W.Sarcomeric protein isoform transitions in cardiac muscle:a journey to heart failure[J].Biochim Biophys Acta,2015,1852(1):47-52. [4]Chang AN,Kamm KE,Stull JT.Role of myosin light chain phosphatase in cardiac physiology and pathophysiology[J].J Mol Cell Cardiol,2016(101):35-43. [5]Egerer E,Siemonsen S,Erbguth F.Acute diseases of the brain and heart:A reciprocal culprit-victim relationship[J].Med Klin Intensivmed Notfmed,2018,113(6):456-463. [6]Kamm KE,Stull JT.Signaling to myosin regulatory light chain in sarcomeres[J].J Biol Chem,2011,286(12):9941-9947. [7]邹松峰,付珺,杨子仪,等.衰老时心肌肌球蛋白轻链激酶(cMLCK)参与调控心肌收缩力的作用机制研究[J].中国地方病防治杂志,2018,33(3):250-252. [8]Khapchaev AY,Shirinsky VP.Myosin Light Chain Kinase MYLK1:Anatomy,Interactions,Functions,and Regulation[J].Biochemistry(Mosc),2016,81(13):1676-1697. [9]Chang AN,Mahajan P,Knapp S,et al.Cardiac myosin light chain is phosphorylated by Ca2+/calmodulin-dependent and-independent kinase activities[J].Proc Natl Acad Sci U S A,2016,113(27):E3824-E3833. [10]Herring BP,Dixon S,Gallagher PJ.Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle[J].AmJ Physiol Cell Physiol,2000,279(5):C1656-C1664. [11]Zhi G,Ryder JW,Huang J,et al.Myosin light chain kinase and myosin phosphorylation effect frequency-dependent potentiation of skeletal muscle contraction[J].Proc Natl Acad Sci U S A,2005,102(48):17519-17524. [12]Davis JS,Hassanzadeh S,Winitsky S,et al.The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation[J].Cell,2001,107(5):631-641. [13]Sheikh F,Lyon RC,Chen J.Functions of myosin light chain-2(MYL2)in cardiac muscle and disease[J].Gene,2015,569(1):14-20. [14]Wang GY,Yeh CC,Jensen BC,et al.Heart failure switches the RV alpha1-adrenergic inotropic response from negative to positive[J].Am J Physiol Heart Circ Physiol,2010,298(3):H913-H920. [15]Rajashree R,Blunt BC,Hofmann PA.Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heart[J].Am J Physiol Heart Circ Physiol,2005,289(4):H1736-H1743. [16]Szczesna-Cordary D,de Tombe PP.Myosin light chain phosphorylation,novel targets to repair a broken heart[J].Cardiovasc Res,2016,111(1):5-7. [17]Pearce WJ.For myosin light chain phosphatase,a very small subunit can make very big differences in the heart[J].Am J Physiol Heart Circ Physiol,2018,314(6):H1157-H1159. [18]Arimura T,Muchir A,Kuwahara M,et al.Overexpression of heart-specific small subunit of myosin light chain phosphatase results in heart failure and conduction disturbance[J].Am J Physiol Heart Circ Physiol,2018,314(6):H1192-H1202. [19]Chang AN,Battiprolu PK,Cowley PM,et al.Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo[J].J Biol Chem,2015,290(17):10703-10716. [20]Massengill MT,Ashraf HM,Chowdhury RR,et al.Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase[J].Cardiovasc Res,2016,111(1):34-43. [21]Hodatsu A,Fujino N,Uyama Y,et al.Impact of cardiac myosin light chain kinase gene mutation on development of dilated cardiomyopathy[J].ESC Heart Fail,2019,6(2):406-415. [22]Kopylova GV,Shchepkin DV,Nabiev SR,et al.Cardiomyopathy-associated mutations in tropomyosin differently affect actin-myosin interaction at single-molecule and ensemble levels[J].J Muscle Res Cell Motil,2019,40(3-4):299-308. [23]Brunello E,Fusi L,Ghisleni A,et al.Myosin filament-based regulation of the dynamics of contraction in heart muscle[J].Proc Natl Acad Sci U S A,2020,117(14):8177-8186. [24]Scruggs SB,Hinken AC,Thawornkaiwong A,et al.Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation[J].J Biol Chem,2009,284(8):5097-5106. [25]Kampourakis T,Sun YB,Irving M.Myosin light chain phosphorylation enhances contraction of heart muscle via structural changes in both thick and thin filaments[J].Proc Natl Acad Sci U S A,2016,113(21):E3039-E3047. [26]Arvanitis M,Tampakakis E,Zhang Y,et al.Genome-wide association and multi-omic analyses reveal ACTN2 as a gene linked to heart failure[J].Nat Commun,2020,11(1):1122. [27]Chiu C,Bagnall RD,Ingles J,et al.Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy:a genome-wide analysis[J].J Am Coll Cardiol,2010,55(11):1127-1135. [28]X Cai L,Tanada Y,D Bello G,et al.Cardiac MLC2 kinase is localized to the Z-disc and interacts with α-actinin2[J].Sci Rep,2019,9(1):12580. [29]Huang J,Shelton JM,Richardson JA,et al.Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy[J].J Biol Chem,2008,283(28):19748-19756. [30]Josephson MP,Sikkink LA,Penheiter AR,et al.Smooth muscle myosin light chain kinase efficiently phosphorylates serine 15 of cardiac myosin regulatory light chain[J].Biochem Biophys Res Commun,2011,416(3-4):367-371. [31]Szczesna D.Regulatory light chains of striated muscle myosin. Structure,function and malfunction[J].Curr Drug Targets Cardiovasc Haematol Disord,2003,3(2):187-197. [32]Sevrieva IR,Brandmeier B,Ponnam S,et al.Cardiac myosin regulatory light chain kinase modulates cardiac contractility by phosphorylating both myosin regulatory light chain and troponin I[J].J Biol Chem,2020,295(14):4398-4410. [33]Warren SA,Briggs LE,Zeng H,et al.Myosin light chain phosphorylation is critical for adaptation to cardiac stress[J].Circulation,2012,126(22):2575-2588. [34]Fazal F,Gu L,Ihnatovych I,et al.Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo[J].Mol Cell Biol,2005,25(14):6259-6266.
相似文献/References:
[1]贺明清,刘孝娅.环磷腺苷葡胺治疗慢性心力衰竭临床疗效观察[J].医学信息,2018,31(10):135.[doi:10.3969/j.issn.1006-1959.2018.10.045]
HE Ming-qing,LIU Xiao-ya.Clinical Efficacy of Cyclic Adenosine Glucosamine in the Treatment of Chronic Heart Failure[J].Medical Information,2018,31(08):135.[doi:10.3969/j.issn.1006-1959.2018.10.045]
[2]李祥敏.多普勒彩超在慢性心力衰竭患者中的诊断特点分析[J].医学信息,2022,35(11):144.[doi:10.3969/j.issn.1006-1959.2022.11.038]
LI Xiang-min.Analysis of Diagnostic Characteristics of Doppler Ultrasound in Patients with Chronic Heart Failure[J].Medical Information,2022,35(08):144.[doi:10.3969/j.issn.1006-1959.2022.11.038]
[3]付 敏.基于医院的延续性护理对慢性心力衰竭患者自我护理能力及生活质量的影响[J].医学信息,2022,35(11):187.[doi:10.3969/j.issn.1006-1959.2022.11.050]
FU Min.Effect of Hospital-based Continuous Nursing on Self-care Ability and Quality of Life in Patients with Chronic Heart Failure[J].Medical Information,2022,35(08):187.[doi:10.3969/j.issn.1006-1959.2022.11.050]
[4]李鹏飞,何荣华,王琼涛,等.单胺氧化酶对老年心力衰竭患者临床应用价值[J].医学信息,2018,31(17):78.[doi:10.3969/j.issn.1006-1959.2018.17.023]
LI Peng-fei,HE Rong-hua,WANG Qiong-tao,et al.Clinical Value of Monoamine Oxidase in Elderly Patients with Heart Failure[J].Medical Information,2018,31(08):78.[doi:10.3969/j.issn.1006-1959.2018.17.023]
[5]曹 云,李树茂,裘 冬,等.益气温阳中药治疗慢性舒张性心力衰竭的疗效观察[J].医学信息,2019,32(01):162.[doi:10.3969/j.issn.1006-1959.2019.01.051]
CAO Yun,LI Shu-mao,QIU Dong,et al.Therapeutic Effect of Yiqiwenyang Chinese Medicine on Chronic Diastolic Heart Failure[J].Medical Information,2019,32(08):162.[doi:10.3969/j.issn.1006-1959.2019.01.051]
[6]李 月,胡 雅,曹春乐,等.慢性心力衰竭患者健康心理控制源与自我管理的相关性研究[J].医学信息,2019,32(05):133.[doi:10.3969/j.issn.1006-1959.2019.05.042]
LI Yue,HU Ya,CAO Chun-le,et al.Correlation between Health Psychological Control Sources and Self-management in Patients with Chronic Heart Failure[J].Medical Information,2019,32(08):133.[doi:10.3969/j.issn.1006-1959.2019.05.042]
[7]韩婷婷,王 虹,吴美美,等.N-proBNP对慢性心衰患者发生肺动脉高压的预测价值[J].医学信息,2019,32(05):114.[doi:10.3969/j.issn.1006-1959.2019.05.035]
HAN Ting-ting,WANG Hong,WU Mei-mei,et al.Predictive Value of N-proBNP for Pulmonary Hypertension in Patients with Chronic Heart Failure[J].Medical Information,2019,32(08):114.[doi:10.3969/j.issn.1006-1959.2019.05.035]
[8]张文波,杨玉雯.希氏束起搏在慢性心力衰竭患者中的应用[J].医学信息,2019,32(10):41.[doi:10.3969/j.issn.1006-1959.2019.10.015]
ZHANG Wen-bo,YANG Yu-wen.Application of His Bundle Pacing in Patients with Chronic Heart Failure[J].Medical Information,2019,32(08):41.[doi:10.3969/j.issn.1006-1959.2019.10.015]
[9]张凤娜,高伟勤.6min步行试验训练对慢性心力衰竭患者心功能的影响[J].医学信息,2019,32(16):97.[doi:10.3969/j.issn.1006-1959.2019.16.030]
ZHANG Feng-na,GAO Wei-qin.The Effect of 6min Walking Test Training on Cardiac Function in
Patients with Chronic Heart Failure[J].Medical Information,2019,32(08):97.[doi:10.3969/j.issn.1006-1959.2019.16.030]
[10]单玉梅.尼可地尔联合单硝酸异山梨酯治疗冠心病慢性心力衰竭的疗效[J].医学信息,2021,34(21):153.[doi:10.3969/j.issn.1006-1959.2021.21.043]
SHAN Yu-mei.Effect of Nicorandil Combined with Isosorbide Mononitrate in the Treatment of Coronary Heart Disease with Chronic Heart Failure[J].Medical Information,2021,34(08):153.[doi:10.3969/j.issn.1006-1959.2021.21.043]